GE HealthCare debuts new wide-bore MRI scanner built with cardiology, oncology in mind

Michael Walter | | Cardiovascular Business | Cardiac Imaging
GE HealthCare SIGNA Sprint MRI

Image courtesy of GE HealthCare.

GE HealthCare has unveiled its newest piece of medical imaging technology, the SIGNA Sprint 1.5T MRI scanner, at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025 meeting in Honolulu, Hawaii. The wide-bore system was built specifically with cardiology and oncology in mind to reduce the high number of annual global deaths from these diseases.

“We are driven to push the boundaries of what’s possible in MRI with our ultra-premium segment, as our goal is to set a new standard in diagnostic research and precision care that allows for earlier clinical detection and treatment response,” Kelly Londy, CEO of MR technologies for GE HealthCare, said in a prepared statement. “We are working to enhance diagnostic capabilities to provide highly accurate imaging with peace of mind for patients. We hope to help clinicians unlock new horizons for research in advanced imaging.”     

One of GE HealthCare’s goals with SIGNA Sprint was to provide 3.0T-like images with a 1.5T machine. The company focused on delivering high-quality diffusion imaging capabilities, for example, and wanted clinicians to have power “previously unattainable” at this strength.

SIGNA Sprint also includes key details intended to make the patient experience as quick and comfortable as possible. The wide-bore opening is 70 cm, for example, and the system also includes GE HealthCare’s blanket-like AIR Coils and a number of built-in artificial intelligence (AI) features that ensure even more challenging anatomies can be effectively imaged.

GE HealthCare said the new MRI scanner has not yet gained U.S. Food and Drug Administration or CE mark approval.

GE HealthCare is also using the ISMRM meeting as an opportunity to showcase other new MR offerings, including its head-only SIGNA Magnus scanner and Sonic DL 3D AI technology.

Related Content:

Tariffs will have a significant impact on the nuclear imaging supply chain in the US
Cardiologists are first in world to use new cooling device to terminate AFib during surgery
AI-enabled CCTA evaluations reduce use of invasive imaging exams
CCTA shows colchicine's impact on atherosclerosis progression
‘A defining moment’: How cardiologists can get the most out of CT-guided PCI
Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Cardiologists, radiologists and surgeons share ‘landmark’ document on assessing prosthetic heart valves with CT
Angiographic catheters recalled due to safety risk
AMA agrees to help after initial request for an independent cardiovascular board was denied
AI model gets helpful heart assessments out of nongated CT scans
Late-breaking clinical trials announced for New York Valves 2025
FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.